Eileen M. O'Reily, MD
Articles
Quality of Life Data for PARP Inhibitor Shows Promise for Pancreatic Cancer Treatment
October 10, 2019
Video
Results from the randomized phase 3 POLO trial are in, and the quality of life data shows promise for patients with metastatic pancreatic cancer who harbor a germline BRCA gene mutation.